0001209191-18-062943.txt : 20181217
0001209191-18-062943.hdr.sgml : 20181217
20181217162622
ACCESSION NUMBER: 0001209191-18-062943
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181213
FILED AS OF DATE: 20181217
DATE AS OF CHANGE: 20181217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARRIGAN EDMUND
CENTRAL INDEX KEY: 0001177917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38697
FILM NUMBER: 181238402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001169245
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 030375697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (610) 981-6500
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY
STREET 2: SUITE 30
CITY: MALVERN
STATE: PA
ZIP: 19355
FORMER COMPANY:
FORMER CONFORMED NAME: Phase Biosciences Inc
DATE OF NAME CHANGE: 20061013
FORMER COMPANY:
FORMER CONFORMED NAME: DT BIOSCIENCES INC
DATE OF NAME CHANGE: 20020315
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-13
0
0001169245
PhaseBio Pharmaceuticals Inc
PHAS
0001177917
HARRIGAN EDMUND
C/O PHASEBIO PHARMACEUTICALS, INC.
1 GREAT VALLEY PARKWAY, SUITE 30
MALVERN
PA
19355
1
0
0
0
Employee Stock Option (right to buy)
3.65
2018-12-13
4
A
0
68966
0.00
A
2028-12-13
Common Stock
68966
68966
D
The shares subject to the option shall vest in equal monthly installments over 36 months on the same day of the month as the Initial Vesting Date, subject to the reporting person's continued service through each such date.
/s/ John Sharp, by power of attorney
2018-12-17